Category

Vascular BioSciences Receives STTR Fast-Track Grant for CAR Liposomes with VA Hospital of Northern California Vascular BioSciences will be collaborating with the VA Hospital of Northern California on the development of CAR liposomes for pulmonary arterial hypertension treatment GOLETA

Vascular BioSciences Announces New Preclinical Research Results Demonstrating Improved Pulmonary Hypertension and Sepsis Survival with CAR Peptide CEO of Vascular BioSciences, David Mann, makes connection between current research and COVID-19 applications Goleta, CA – Vascular BioScie

FDA Grants Vascular BioSciences Humanitarian Use Device (HUD) Designation to the Endoarterial Biopsy Catheter for Group 1 Pulmonary Arterial Hypertension Humanitarian Use Device (HUD) designation from the U.S. Food and Drug Administration (FDA) for the Endoarterial Biopsy Catheter (EA

Vascular BioSciences Presented Results of CAR Peptide Targeted Augmentation of Chronic Prostanoid Treatment in PAH at the ATS Meeting in Dallas, Texas New data on beneficial effects of co-administration of CAR peptide with treprostinil in experimental pulmonary hypertension GOLETA — V

Vascular BioSciences Awarded $2 Million Phase II STTR Grant From NHLBI to Develop CAR Peptide as a Targeted Therapy for Pulmonary Hypertension Grant awarded in partnership with Brigham and Women’s Hospital, Harvard Medical School Durham, North Carolina – Vascular BioSciences (VB

Vascular BioSciences Awarded Up To $2.3 Million Fast-Track STTR Grant From NHLBI To Develop CAR Peptide For Pulmonary Hypertension Project to be Conducted in Collaboration with Brigham and Women’s Hospital, Harvard Medical School. Durham, North Carolina, August 15th, 2017 – Vascular B

Vascular BioSciences Announces Publication of “Assessment of microRNA and gene dysregulaton in pulmonary hypertension by endoarterial biopsy” in the Current Issue of Pulmonary Circulation Goleta, CA., May 19, 2017 – Vascular BioSciences announces publication of “Assessment of mi

Vascular BioSciences announces publication of “Challenges in the development of chronic pulmonary hypertension models in large animals” in the Current Issue of Pulmonary Circulation Goleta, CA., February 1, 2017 – Vascular BioSciences announces publication of “Challenges in the

Vascular BioSciences’ Sepsis Research Wins Award at the 46th Annual Critical Care Congress of the Society of Critical Care Medicine Hydrocortisone Therapy with CAR Peptide Protects the Injured Endothelial Glycocalyx in Sepsis. Honolulu, HI, January 22, 2017 – On January 22

Vascular BioSciences congratulates VP of Communications, Dr. Susana Peinado, Ph.D., on being awarded her Doctorate from UCSB School of Communication Goleta, Ca, June 7, 2016 — Vascular BioSciences announced today that Dr. Susana Peinado, Ph.D., Vice President of Communications at Vasc